YU51092A - Novi derivati tiopiranopirola i njihovo dobijanje - Google Patents

Novi derivati tiopiranopirola i njihovo dobijanje

Info

Publication number
YU51092A
YU51092A YU51092A YU51092A YU51092A YU 51092 A YU51092 A YU 51092A YU 51092 A YU51092 A YU 51092A YU 51092 A YU51092 A YU 51092A YU 51092 A YU51092 A YU 51092A
Authority
YU
Yugoslavia
Prior art keywords
derivatives
denotes
radical
new
thiopyranopyroly
Prior art date
Application number
YU51092A
Other languages
English (en)
Inventor
C. Moutonnier
J.F. Peyronel
M. Tabart
A. Truchon
Original Assignee
Rhone-Poulenc Rorer S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone-Poulenc Rorer S.A. filed Critical Rhone-Poulenc Rorer S.A.
Publication of YU51092A publication Critical patent/YU51092A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Novi derivati tiopiranopirola opšte formule (I) - CRaRbRc u kojoj R označava vodonik, alil ili radikal strukture, a u kojoj su Ra i Rb atomi vodonika ili radikali fenil koji su u datom slučaju supstituisani (halogenom, alkilom, alkiloksigrupom ili nitro-grupom), i Rc je definisan kao Ra i Rb ili označava radikal alkil ili alkiloksialkil, pri čemu najmanje jedan od simbola Ra, Rb i Rc označava fenil-radikal koji je supstituisan ili nije supstituisan, i n = 0 do 2, u njihovim oblicima stereoizomera i njihovih smeša, u datom slučaju u obliku njihovih soli kada ove postoje, i njihovo dobijanje. Ovi novi derivati prema pronalasku su naročito značajni kao inter-medijeri u sintezi.
YU51092A 1991-05-17 1992-05-14 Novi derivati tiopiranopirola i njihovo dobijanje YU51092A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9106038A FR2676447B1 (fr) 1991-05-17 1991-05-17 Nouveaux derives du thiopyranopyrrole et leur preparation.

Publications (1)

Publication Number Publication Date
YU51092A true YU51092A (sh) 1994-06-10

Family

ID=9412910

Family Applications (1)

Application Number Title Priority Date Filing Date
YU51092A YU51092A (sh) 1991-05-17 1992-05-14 Novi derivati tiopiranopirola i njihovo dobijanje

Country Status (18)

Country Link
US (1) US5484942A (sh)
EP (2) EP0514276A1 (sh)
JP (1) JPH06507895A (sh)
AU (1) AU653032B2 (sh)
CA (1) CA2109295A1 (sh)
CZ (1) CZ245093A3 (sh)
FI (1) FI935074A0 (sh)
FR (1) FR2676447B1 (sh)
HU (1) HUT65590A (sh)
IE (1) IE921544A1 (sh)
IL (1) IL101865A0 (sh)
MX (1) MX9202290A (sh)
NO (1) NO933690L (sh)
NZ (1) NZ242738A (sh)
SK (1) SK126693A3 (sh)
WO (1) WO1992020686A1 (sh)
YU (1) YU51092A (sh)
ZA (1) ZA923516B (sh)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2676446B1 (fr) * 1991-05-17 1993-08-06 Rhone Poulenc Rorer Sa Nouveaux derives du thiopyranopyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent.
FR2728166A1 (fr) 1994-12-19 1996-06-21 Oreal Composition topique contenant un antagoniste de substance p
FR2728165A1 (fr) 1994-12-19 1996-06-21 Oreal Utilisation d'un antagoniste de substance p pour le traitement des rougeurs cutanees d'origine neurogene
FR2728169A1 (fr) 1994-12-19 1996-06-21 Oreal Utilisation d'un antagoniste de substance p pour le traitement des prurits et des dysesthesies oculaires ou palpebrales
FR2741262B1 (fr) 1995-11-20 1999-03-05 Oreal Utilisation d'un antagoniste de tnf-alpha pour le traitement des rougeurs cutanees d'origine neurogene
US7163949B1 (en) 1999-11-03 2007-01-16 Amr Technology, Inc. 4-phenyl substituted tetrahydroisoquinolines and use thereof
AU781179B2 (en) 1999-11-03 2005-05-12 Albany Molecular Research, Inc. Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
US7084152B2 (en) 2000-07-11 2006-08-01 Amr Technology, Inc. 4-phenyl substituted tetrahydroisoquinolines therapeutic use thereof
EP1778639B1 (en) 2004-07-15 2015-09-02 Albany Molecular Research, Inc. Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
WO2006123182A2 (en) 2005-05-17 2006-11-23 Merck Sharp & Dohme Limited Cyclohexyl sulphones for treatment of cancer
KR20080044840A (ko) 2005-07-15 2008-05-21 에이엠알 테크놀로지, 인크. 아릴- 및 헤테로아릴-치환된 테트라히드로벤자제핀, 및노르에피네프린, 도파민 및 세로토닌의 재흡수를 차단하기위한 용도
GB0603041D0 (en) 2006-02-15 2006-03-29 Angeletti P Ist Richerche Bio Therapeutic compounds
US20110218176A1 (en) 2006-11-01 2011-09-08 Barbara Brooke Jennings-Spring Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
AU2008204380B2 (en) 2007-01-10 2013-08-15 Msd Italia S.R.L. Amide substituted indazoles as poly(ADP-ribose)polymerase (PARP) inhibitors
EP2170076B1 (en) 2007-06-27 2016-05-18 Merck Sharp & Dohme Corp. 4-carboxybenzylamino derivatives as histone deacetylase inhibitors
AR071997A1 (es) 2008-06-04 2010-07-28 Bristol Myers Squibb Co Forma cristalina de 6-((4s)-2-metil-4-(2-naftil)-1,2,3,4-tetrahidroisoquinolin-7-il)piridazin-3-amina
US9156812B2 (en) 2008-06-04 2015-10-13 Bristol-Myers Squibb Company Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
WO2010114780A1 (en) 2009-04-01 2010-10-07 Merck Sharp & Dohme Corp. Inhibitors of akt activity
KR101830447B1 (ko) 2009-05-12 2018-02-20 알바니 몰레큘라 리써치, 인크. 7-(［1,2,4］트리아졸로［1,5-α］피리딘-6-일)-4-(3,4-디클로로페닐)-1,2,3,4-테트라하이드로이소퀴놀린 및 이의 용도
CN102638982B (zh) 2009-05-12 2015-07-08 百时美施贵宝公司 (S)-7-([1,2,4]三唑并[1,5-a]吡啶-6-基)-4-(3,4-二氯苯基)-1,2,3,4-四氢异喹啉的晶型及其用途
MX2011011901A (es) 2009-05-12 2012-01-20 Albany Molecular Res Inc Tetrahidroisoquinolinas aril, heteroaril, y heterociclo sustituidas y uso de las mismas.
MX2012004377A (es) 2009-10-14 2012-06-01 Merck Sharp & Dohme Piperidinas sustituidas que aumentan la actividad de p53 y sus usos.
EP3330377A1 (en) 2010-08-02 2018-06-06 Sirna Therapeutics, Inc. Rna interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (ctnnb1) gene expression using short interfering nucleic acid (sina)
EP2606134B1 (en) 2010-08-17 2019-04-10 Sirna Therapeutics, Inc. RNA INTERFERENCE MEDIATED INHIBITION OF HEPATITIS B VIRUS (HBV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
US8883801B2 (en) 2010-08-23 2014-11-11 Merck Sharp & Dohme Corp. Substituted pyrazolo[1,5-a]pyrimidines as mTOR inhibitors
EP2613782B1 (en) 2010-09-01 2016-11-02 Merck Sharp & Dohme Corp. Indazole derivatives useful as erk inhibitors
EP2615916B1 (en) 2010-09-16 2017-01-04 Merck Sharp & Dohme Corp. Fused pyrazole derivatives as novel erk inhibitors
ES2663009T3 (es) 2010-10-29 2018-04-10 Sirna Therapeutics, Inc. Inhibición de la expresión génica mediada por interferencia por ARN utilizando ácidos nucleicos de interferencia cortos (ANic)
WO2012087772A1 (en) 2010-12-21 2012-06-28 Schering Corporation Indazole derivatives useful as erk inhibitors
CN103732592A (zh) 2011-04-21 2014-04-16 默沙东公司 胰岛素样生长因子-1受体抑制剂
WO2013063214A1 (en) 2011-10-27 2013-05-02 Merck Sharp & Dohme Corp. Novel compounds that are erk inhibitors
EP3919620A1 (en) 2012-05-02 2021-12-08 Sirna Therapeutics, Inc. Short interfering nucleic acid (sina) compositions
RU2660429C2 (ru) 2012-09-28 2018-07-06 Мерк Шарп И Доум Корп. Новые соединения, которые являются ингибиторами erk
JP6290237B2 (ja) 2012-11-28 2018-03-07 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． 癌を処置するための組成物および方法
AR094116A1 (es) 2012-12-20 2015-07-08 Merck Sharp & Dohme Imidazopiridinas sustituidas como inhibidores de hdm2
EP2951180B1 (en) 2013-01-30 2018-05-02 Merck Sharp & Dohme Corp. 2,6,7,8 substituted purines as hdm2 inhibitors
WO2015034925A1 (en) 2013-09-03 2015-03-12 Moderna Therapeutics, Inc. Circular polynucleotides
WO2018071283A1 (en) 2016-10-12 2018-04-19 Merck Sharp & Dohme Corp. Kdm5 inhibitors
WO2019094311A1 (en) 2017-11-08 2019-05-16 Merck Sharp & Dohme Corp. Prmt5 inhibitors
US11981701B2 (en) 2018-08-07 2024-05-14 Merck Sharp & Dohme Llc PRMT5 inhibitors
US11993602B2 (en) 2018-08-07 2024-05-28 Merck Sharp & Dohme Llc PRMT5 inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4042707A (en) * 1976-02-19 1977-08-16 E. I. Du Pont De Nemours And Company 3α-Arylhydroisoindoles
AU502760B2 (en) * 1977-02-28 1979-08-09 Science Union Et Cie, Societe Francaise De Recherche Medicale Azabicycloalkanes and their preparation
DE3276311D1 (en) * 1981-02-17 1987-06-19 Warner Lambert Co Octahydro-2-(omega-mercaptoalkanoyl)3-oxo-1h-isoindole-1-carboxylic acids and esters
US4439229A (en) * 1981-06-29 1984-03-27 Rohm And Haas Company Substituted phthalimides herbicides
US4503043A (en) * 1981-12-07 1985-03-05 Warner-Lambert Company Substituted acyl derivatives of octahydro-1H-isoindole-1-carboxylic acids
JPH0278659A (ja) * 1988-09-12 1990-03-19 Shionogi & Co Ltd アザビシクロアルカン類化合物
FR2676446B1 (fr) * 1991-05-17 1993-08-06 Rhone Poulenc Rorer Sa Nouveaux derives du thiopyranopyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
CA2109295A1 (fr) 1992-11-18
HUT65590A (en) 1994-07-28
IL101865A0 (en) 1992-12-30
ZA923516B (en) 1993-02-24
MX9202290A (es) 1993-02-01
EP0587673A1 (fr) 1994-03-23
SK126693A3 (en) 1994-05-11
EP0514276A1 (fr) 1992-11-19
AU1913792A (en) 1992-12-30
FI935074A (fi) 1993-11-16
NO933690D0 (no) 1993-10-13
CZ245093A3 (en) 1994-03-16
NZ242738A (en) 1994-07-26
FR2676447B1 (fr) 1993-08-06
US5484942A (en) 1996-01-16
AU653032B2 (en) 1994-09-15
WO1992020686A1 (fr) 1992-11-26
NO933690L (no) 1993-10-13
IE921544A1 (en) 1992-11-18
JPH06507895A (ja) 1994-09-08
FR2676447A1 (fr) 1992-11-20
HU9303251D0 (en) 1994-03-28
FI935074A0 (fi) 1993-11-16

Similar Documents

Publication Publication Date Title
YU51092A (sh) Novi derivati tiopiranopirola i njihovo dobijanje
ATE214393T1 (de) Bis(3,4-dialkylbenzyliden)sorbitolacetale und diese enthaltende zusammensetzungen
ES527954A1 (es) Un procedimiento para preparar isoxazoles
ZA817314B (en) Novel compounds belonging to the family of the benzoyl-and alpha-hydroxybenzyl-phenyl-osides,their method of preparation and application thereof in therapeutics
SE7602122L (sv) Nya piperazinyliminorifamyciner och sett att framstella desamma
AR005672A1 (es) Derivados de la distamicina, proceso para prepararlos, y su utilizacion como agentes antitumorales y antivirales.
FR2379581A1 (fr) Colorants fluorescents derives de la coumarine
SE7501365L (sh)
PT763024E (pt) Novos processos e intermediarios para a preparacao de derivados de piperazina
DE3171116D1 (en) Arylamine derivatives, process for their preparation and their use as microbicides
ES8504722A1 (es) Un metodo de preparar derivados de 4-quinolona
FR2367742A1 (fr) Derives d'a-thio-alcanoiques, leur preparation et leur utilisation
FR2394584A1 (fr) Melanges de composes azoiques utilisables comme pigments
YU205390A (sh) Novi derivati 1,8-benzonaftiridina, njihovo dobijanje i smeše koje ih sadrže
AR009666A1 (es) Compuestos derivados de carboxamida ciclicos sustituidos con carboxi, composicion farmaceutica, usos en la fabricacion de composiciones farmaceuticas para el asma, la tos y la bronquitis y procedimiento de preparacion
SE7706655L (sv) Nya bensylcyanoacetaler och sett att framstella dessa
SE7909751L (sv) 4,1-bensoxazepiner och tia-analoger derav
ES8206550A1 (es) Un procedimiento para la preparacion de derivados de 2-desoxi-3-5-di-o-alquilcarbonil-5-fluorurina.
FR2358449A1 (fr) Nouveaux derives de l'iso-indolinone utilisables comme pigments et leur preparation
RS50790B (sr) Korišćenje derivata piridoindolona za spravljanje lekova
DE69011714D1 (de) Kalziumantagonisten.
FR2356414A1 (fr) Utilisation de 1,4 dioxannes portant des substituants alkyle comme matieres aromatiques et compositions de parfum en contenant
US4226984A (en) 2-Decarboxy-2-aminomethyl-trans-4,5-didehydro-PGI1 compounds
ATE48423T1 (de) 1,3-dioxan 5-yl-alkyltriazole, ihre herstellung, ihre verwendung zur regulierung des pflanzenwachstums und mittel dafuer.
ES2081957T3 (es) Nuevos derivados sustituidos en posicion 15, de la 20,21-dinoreburnamenina, su procedimiento de preparacion y los nuevos productos intermedios asi obtenidos, su aplicacion como medicamentos y composiciones que los contienen.